Le Hellard, S., Theisen, F. M., Haberhausen, M., Raeder, M. B., Fernø, J., Gebhardt, S., . . . Steen, V. M. (2009). Association between the insulin-induced gene 2 (INSIG2) and weight gain in a German sample of antipsychotic-treated schizophrenic patients: Perturbation of SREBP-controlled lipogenesis in drug-related metabolic adverse effects? Molecular Psychiatry, 14(3), 308. https://doi.org/10.1038/sj.mp.4002133
Chicago Style (17th ed.) CitationLe Hellard, S., et al. "Association Between the Insulin-induced Gene 2 (INSIG2) and Weight Gain in a German Sample of Antipsychotic-treated Schizophrenic Patients: Perturbation of SREBP-controlled Lipogenesis in Drug-related Metabolic Adverse Effects?" Molecular Psychiatry 14, no. 3 (2009): 308. https://doi.org/10.1038/sj.mp.4002133.
MLA (9th ed.) CitationLe Hellard, S., et al. "Association Between the Insulin-induced Gene 2 (INSIG2) and Weight Gain in a German Sample of Antipsychotic-treated Schizophrenic Patients: Perturbation of SREBP-controlled Lipogenesis in Drug-related Metabolic Adverse Effects?" Molecular Psychiatry, vol. 14, no. 3, 2009, p. 308, https://doi.org/10.1038/sj.mp.4002133.
